Post-IPO Equity Biotechnology Companies

Coherus Biosciences develops, manufactures, and commercializes biologic therapeutics for oncology and inflammatory diseases.

Evommune is a biotechnology company that develops therapeutics that halt progressive disease and address their symptoms.

Aligos Therapeutics is discovering and developing new classes of molecules that interact directly with disease-causing modalities.

Xilio Therapeutics is a biotechnology company that develops tumor-activated immuno-oncology therapies.

Galecto is a clinical stage biotechnology company focused on the development of novel treatments for fibrosis and cancer.

Foghorn Therapeutics is developing therapies based on a system that directs which genes our cells express,

RadioPharm Theranostics is a platform of radiopharmaceutical and nuclear medicine products for diagnostic and therapeutic uses.

Century Therapeutics is a biotechnology company that develops cell therapies for hematological and solid tumor malignancies.

Monte Rosa Therapeutics is a biotechnology company that develops cancer therapeutics that modulate protein degradation pathways.

Phathom Pharmaceuticals is a biopharmaceutical company.

Bright Minds Biosciences is a biotech company that engages in the development of serotonergic therapeutics to treat mental health disorders.

Alumis is a precision medicine company focused on the discovery, development and treatment of autoimmune disorders.

Praxis develops therapies for CNS disorders by leveraging genetic insights into neuronal imbalances, targeting rare to common conditions.

Harvard Apparatus Regenerative Technology is a biotechnology firm developing esophageal implants for patients battling threatening condition

Estrella Immunopharma develops transformative cancer medicines with CD19-Redirected ARTEMIS T Cells to improve patients’ lives.

Voyager Therapeutics is a biotechnology company specializing in gene therapy and neurology.

Keros is a clinical-stage biopharmaceutical company focusing on the discovery, development, and commercialization of novel treatments.

Coya Therapeutics is a T Reg platform company addressing neurodegenerative, autoimmune, and metabolic diseases

Vaxcyte focuses on developing vaccines designed to prevent or treat some of the most common and deadly infectious diseases worldwide.

Mirxes is an RNA technology company that develops blood-based miRNA test kits for early disease detection.

Inify Laboratories provides cancer diagnostics through ultra-modern laboratory services within pathology.

Terns Pharmaceuticals develops small-molecule therapies for chronic diseases including cancer, metabolic disorders, and liver conditions.

Vera Therapeutics is a biotechnology company developing innovative biologic therapeutics with transformative clinical potential.

Structure Therapeutics specializes in the discovery and development of drugs against a type of targets called GPCR.

Wave Life Sciences is a clinical-stage RNA medicines company committed to delivering life-changing treatments for people battling diseases